V
VelarionIntelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Becton Dickinson & Co Executive Compensation (FY25)

BDX · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): January 30, 2026
260 figures on this page: 251 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
Thomas Polen, Chairman, Chief Executive Officer and President, received $17,129,140 in total compensation for fiscal 2025, and compared with the $17,314,606 reported for fiscal 2024, Polen's total was 1.1% lower. Separately, for fiscal 2025, the company reported a chief executive pay ratio of 374:1, against median employee compensation of $45,831. Meanwhile, the say-on-pay proposal drew 91.4% of votes cast for or against in favor at the meeting held January 27, 2026 for fiscal 2025. Companies named in the disclosed peer group include Abbott Laboratories, Agilent Technologies, Inc., Baxter International Inc., Boston Scientific Corporation and Danaher Corporation, among others.
Chief executive, fiscal 2025
Thomas Polen
Latest say-on-pay support
=
January 27, 2026
Chief executive pay ratio
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Thomas Polen: $17,314,606$17,129,140 (1.1% lower)
Say-on-pay support: 89.0%91.4% (2.4 points higher)
CEO pay ratio: 396:1374:1 (5.6% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Becton Dickinson & Co's chief executive and what were they paid?
Thomas Polen, Chairman, Chief Executive Officer and President, received $17,129,140 in total compensation for fiscal 2025. Compared with the $17,314,606 reported for fiscal 2024, Polen's total was 1.1% lower.
What was Becton Dickinson & Co's say-on-pay result?
The say-on-pay proposal drew 91.4% of votes cast for or against in favor at the meeting held January 27, 2026 for fiscal 2025.
Which companies are in Becton Dickinson & Co's peer group?
Companies named in the disclosed peer group include Abbott Laboratories, Agilent Technologies, Inc., Baxter International Inc., Boston Scientific Corporation and Danaher Corporation, among others.
What is Becton Dickinson & Co's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 374:1, against median employee compensation of $45,831.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
Richard Byrd
Executive Vice President and President, Interventional Segment
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
Michael Feld
Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
Richard Byrd
Executive Vice President and President, Interventional Segment
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Christopher J. DelOreficeRSU
Christopher J. DelOreficeOPTION
Christopher J. DelOreficePSU
Michael C. FeldOPTION
Michael C. FeldRSU
Michael C. FeldPSU
Michael D. GarrisonRSU
Michael D. GarrisonPSU
Michael D. GarrisonOPTION
Richard E. ByrdPSU
Richard E. ByrdOPTION
Richard E. ByrdRSU
Thomas E. PolenRSU
Thomas E. PolenPSU
Thomas E. PolenOPTION
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Richard ByrdSAR11/26/2034
SAR11/26/2032
SAR11/26/2031
PSU
RSU
SAR11/26/2033
Michael GarrisonRSU
SAR11/26/2032
SAR11/26/2031
PSU
SAR11/26/2033
SAR11/26/2034
Christopher DelOreficeRSU
PSU
SAR11/26/2034
SAR11/26/2032
SAR11/26/2031
SAR11/26/2033
Thomas PolenRSU
SAR11/26/2032
SAR11/26/2034
SAR11/26/2031
PSU
SAR11/26/2033
Michael FeldPSU
RSU
SAR11/26/2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Bertram L. Scott
Lead independent director
R. Andrew Eckert
Christopher Jones
Catherine M. Burzik
Jeffrey W. Henderson
Carrie L. Byington
Claire M. Fraser
Joanne Waldstreicher
Timothy M. Ring
William M. Brown
Gregory J. Hayes
Thomas E. Polen, Jacqueline Wright and Robert L. Huffines served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer
Board equity retainer
Total board retainer
Lead independent director premium
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x annual cash retainer ($600,000)

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Abbott Laboratories ABT
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Boston Scientific Corporation BSX
  • Danaher Corporation DHR
  • GE Healthcare Technologies, Inc. GEHC
  • Medtronic plc MDT
  • Stryker Corporation SYK
  • Thermo Fisher Scientific Inc. TMO
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025January 27, 2026=
2024January 28, 2025=
2023January 23, 2024=
2022January 24, 2023=
2021January 25, 2022=
2020January 26, 2021=
2019January 28, 2020=
2018January 22, 2019=
2017January 23, 2018=

Chief executive pay ratio

As calculated and reported by the company.
Ratio
Median employee compensation
Chief executive total compensation
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Becton Dickinson & Co files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Becton Dickinson & Co disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Becton Dickinson & Co sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Becton Dickinson & Co's disclosed peer group is defensible, who names Becton Dickinson & Co back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
260 figures on this page: 251 cited to the filing that reported them, 9 calculated from figures it prints.
251 cited to the filing
9 calculated from the filing

Documents cited

  1. 0001628280-26-004393
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001628280-25-057846
    CEO Pay Ratio · Fiscal 2025 director compensation · Fiscal year 2025 summary compensation table · Grants of Plan-Based Awards · and 3 more sections
  3. 0000010795-25-000011
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000010795-24-000096
    Fiscal year 2024 summary compensation table
  5. 0000010795-24-000006
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000010795-23-000118
    Fiscal year 2023 summary compensation table
  7. 0000010795-23-000015
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000010795-22-000007
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000010795-21-000019
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000010795-20-000003
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000010795-19-000004
  12. 0001628280-18-000557
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Becton Dickinson & Co executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/BDX (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Becton Dickinson & Co and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive payMedTech & DiagnosticsCEO pay ratioMedTech & DiagnosticsSay-on-pay supportMedTech & Diagnostics

Peers Becton Dickinson & Co discloses

The companies named in BDX's own disclosed peer group.

Abbott LaboratoriesAgilent Technologies, Inc.Baxter International Inc.Boston Scientific CorporationGE Healthcare Technologies, Inc.Medtronic plcStryker CorporationZimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy